Author | Lisa LaMotta


5-FU Dose Optimization: Another Step Towards Personalizing Cancer Care

May 05, 2010


According to the Centers for Disease Control and Prevention, colorectal cancer is the second leading cancer killer in the United States, affecting both men and women.

5-FU Dose Optimization: Another Step toward Personalizing Cancer Care

September 18, 2009


Until the mid-90s, the only approved agent for treating this cancer was 5-fluorouracil (5-FU), and although other agents are now readily available, 5-FU is commonly used as a backbone of combination chemotherapy.